The most honest assessment is that it helps prevent deficiencies and supports overall health during GLP-1 therapy, but it will not dramatically accelerate weight loss, eliminate all side effects, or replace the need for a nutrient-dense diet
Wegovy cardiovascular risk reduction In March 2024, the FDA approved Wegovy for reducing the risk of major adverse cardiovascular events (heart attack, stroke, and cardiovascular death) in adults with established cardiovascular disease and overweight or obesity
How a Lizards Venom Gave Us a New Class of Diabetes Drugs. Science magazine
Hims & Hers Super Bowl commercial that featured its compounded weight loss offerings resulted in a 650% spike in engagement with record-high customer registrations, according to data that the company shared with Fierce Healthcare
Throughout treatment, patients taking insulin or sulfonylureas should continue to monitor for hypoglycemia, as dose reductions of these medications may be necessary
Stomach lining cells also adjust their mucus production and acid secretion to accommodate slower emptying, reducing irritation and reflux risk